The estimated Net Worth of John R Considine is at least $42 Million dollars as of 4 February 2009. John Considine owns over 90,000 units of Becton Dickinson & Co stock worth over $41,982,409 and over the last 21 years John sold BDX stock worth over $0.
John has made over 12 trades of the Becton Dickinson & Co stock since 2004, according to the Form 4 filled with the SEC. Most recently John exercised 90,000 units of BDX stock worth $2,699,100 on 4 February 2009.
The largest trade John's ever made was exercising 150,000 units of Becton Dickinson & Co stock on 10 November 2004 worth over $4,167,000. On average, John trades about 7,035 units every 9 days since 2003. As of 4 February 2009 John still owns at least 179,650 units of Becton Dickinson & Co stock.
You can see the complete history of John Considine stock trades at the bottom of the page.
John's mailing address filed with the SEC is , , , , .
Over the last 22 years, insiders at Becton Dickinson & Co have traded over $106,782,599 worth of Becton Dickinson & Co stock and bought 23,860 units worth $1,771,828 . The most active insiders traders include Edward J Ludwig, William M Brown, and Vincent A Forlenza. On average, Becton Dickinson & Co executives and independent directors trade stock every 20 days with the average trade being worth of $4,349,205. The most recent stock trade was executed by Roland Goette on 14 August 2024, trading 5,295 units of BDX stock currently worth $701,799.
Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others.
Becton Dickinson & Co executives and other stock owners filed with the SEC include: